blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3334759

EP3334759 - LACTOFERRIN FRAGMENT FOR THE USE AS ANTIBACTERIAL AND ANTIVIRAL AGENT [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.07.2020
Database last updated on 30.10.2024
FormerThe patent has been granted
Status updated on  02.08.2019
FormerGrant of patent is intended
Status updated on  01.04.2019
FormerRequest for examination was made
Status updated on  18.05.2018
FormerThe international publication has been made
Status updated on  18.02.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Farmagens Health Care Srl
Via F.S. Nitti, 15
00191 Roma / IT
[2019/16]
Former [2018/25]For all designated states
Farmagens Health Care Srl
Via F.S. Nitti, 15
00191 Rome / IT
Inventor(s)01 / SANNETTI, Augusto
Via A. Solivetti 19
I-00168 Roma / IT
02 / PAGANO, Francesco
Via Pietro Pagliuca 27
I-81030 Cancello ed Arnone (CE) / IT
03 / GALDIERO, Stefania
Via Marechiaro 15C
I-80123 Napoli / IT
04 / GALDIERO, Massimiliano
Via Marechiaro 26
I-80123 Napoli / IT
 [2018/42]
Former [2018/25]01 / SANNETTI, Augusto
Via A. Solivetti 19
I-00168 Roma / IT
02 / PAGANO, Francesco
Via Pietro Pagliuca 27
I-81030 Cancello ed Arnone (CE) / IT
03 / GALDIERO, Stefania
Via Marechiaro 15C
I-80123 Napoli / IT
04 / GALDIERO, Massimiliano
Via Marechiaro 21
I-80123 Napoli / IT
Representative(s)Sarpi, Maurizio, et al
Studio Ferrario S.r.l.
Via Collina, 36
00187 Roma / IT
[2018/25]
Application number, filing date16763573.928.07.2016
[2018/25]
WO2016IB54513
Priority number, dateIT2015UB0305811.08.2015         Original published format: IT UB20153058
[2018/25]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017025846
Date:16.02.2017
Language:EN
[2017/07]
Type: A1 Application with search report 
No.:EP3334759
Date:20.06.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 16.02.2017 takes the place of the publication of the European patent application.
[2018/25]
Type: B1 Patent specification 
No.:EP3334759
Date:04.09.2019
Language:EN
[2019/36]
Search report(s)International search report - published on:EP16.02.2017
ClassificationIPC:C07K14/79, A61K38/40, A61K38/00
[2019/09]
CPC:
C07K14/79 (EP); A61K38/40 (EP); A61K38/00 (EP)
Former IPC [2018/25]C07K14/79, A61K38/40
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/25]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:LACTOFERRIN-FRAGMENT ZUR VERWENDUNG ALS BAKTERIZID UND VIRUZID[2018/25]
English:LACTOFERRIN FRAGMENT FOR THE USE AS ANTIBACTERIAL AND ANTIVIRAL AGENT[2018/25]
French:FRAGMENT DE LACTOFERRINE DESTINÉ À ÊTRE UTILISÉ EN TANT QU'AGENT ANTIBACTÉRIEN ET ANTIVIRAL[2018/25]
Entry into regional phase08.03.2018National basic fee paid 
08.03.2018Designation fee(s) paid 
08.03.2018Examination fee paid 
Examination procedure08.03.2018Examination requested  [2018/25]
08.03.2018Date on which the examining division has become responsible
10.09.2018Amendment by applicant (claims and/or description)
02.04.2019Communication of intention to grant the patent
25.07.2019Fee for grant paid
25.07.2019Fee for publishing/printing paid
25.07.2019Receipt of the translation of the claim(s)
Opposition(s)05.06.2020No opposition filed within time limit [2020/33]
Fees paidRenewal fee
26.07.2018Renewal fee patent year 03
11.07.2019Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU28.07.2016
AL04.09.2019
AT04.09.2019
CY04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
MC04.09.2019
MK04.09.2019
MT04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SI04.09.2019
SK04.09.2019
SM04.09.2019
TR04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IS05.01.2020
PT06.01.2020
[2022/32]
Former [2022/27]HU28.07.2016
AL04.09.2019
AT04.09.2019
CY04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
MC04.09.2019
MT04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SI04.09.2019
SK04.09.2019
SM04.09.2019
TR04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IS05.01.2020
PT06.01.2020
Former [2021/15]AL04.09.2019
AT04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
MC04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SI04.09.2019
SK04.09.2019
SM04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IS05.01.2020
PT06.01.2020
Former [2020/37]AL04.09.2019
AT04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SI04.09.2019
SK04.09.2019
SM04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IS05.01.2020
PT06.01.2020
Former [2020/36]AL04.09.2019
AT04.09.2019
CZ04.09.2019
DK04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SK04.09.2019
SM04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
IS05.01.2020
PT06.01.2020
Former [2020/27]AL04.09.2019
AT04.09.2019
CZ04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SK04.09.2019
SM04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
PT06.01.2020
IS24.02.2020
Former [2020/25]AL04.09.2019
AT04.09.2019
CZ04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
SK04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
PT06.01.2020
IS24.02.2020
Former [2020/23]AL04.09.2019
AT04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
NL04.09.2019
PL04.09.2019
RO04.09.2019
RS04.09.2019
SE04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
PT06.01.2020
Former [2020/22]AL04.09.2019
EE04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
NL04.09.2019
RS04.09.2019
SE04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
PT06.01.2020
Former [2020/20]AL04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
NL04.09.2019
RS04.09.2019
SE04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
Former [2020/15]AL04.09.2019
FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
RS04.09.2019
SE04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
Former [2020/12]FI04.09.2019
HR04.09.2019
LT04.09.2019
LV04.09.2019
RS04.09.2019
SE04.09.2019
BG04.12.2019
NO04.12.2019
GR05.12.2019
Former [2020/10]FI04.09.2019
LT04.09.2019
SE04.09.2019
BG04.12.2019
NO04.12.2019
Former [2020/09]FI04.09.2019
LT04.09.2019
NO04.12.2019
Former [2020/08]LT04.09.2019
NO04.12.2019
Cited inInternational search[Y]WO0012542  (ALPHARMA AS [NO], et al) [Y] 1-22 * whole document, especially the claims *;
 [Y]WO2004089986  (STICHTING TECH WETENSCHAPP [NL], et al) [Y] 1-22 * whole document, especially the claims *;
 [Y]  - RASTOGI NILISHA ET AL, "Preparation and Antimicrobial Action of Three Tryptic Digested Functional Molecules of Bovine Lactoferrin", PLOS ONE, (201403), vol. 9, no. 3, XP002756217 [Y] 1-22 * the whole document *

DOI:   http://dx.doi.org/10.1371/journal.pone.0090011
 [A]  - Marieke I.A Van Der Kraan ET AL, "Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin", Peptides, United States, doi:10.1016/j.peptides.2003.12.006, (20040101), pages 177 - 183, URL: http://www.sciencedirect.com/science/article/pii/S0196978103004121/pdfft?md5=23ba10c3fd4822f2b9ad62723ace4f48&pid=1-s2.0-S0196978103004121-main.pdf, (20160406), XP055263437 [A] 1-22 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.peptides.2003.12.006
 [A]  - GHOSH ANIRBAN ET AL, "Sequence context induced antimicrobial activity: insight into lipopolysaccharide permeabilization", MOLECULAR BIOSYSTEMS, (2014), vol. 10, no. 6, pages 1596 - 1612, XP002756218 [A] 1-22 * abstract *

DOI:   http://dx.doi.org/10.1039/c4mb00111g
 [A]  - VAN DER KRAAN M I A ET AL, "Ultrastructural effects of antimicrobial peptides from bovine lactoferrin on the membranes of Candida albicans and Escherichia coli", PEPTIDES, ELSEVIER, AMSTERDAM, NL, vol. 26, no. 9, ISSN 0196-9781, (20050901), pages 1537 - 1542, (20050901), XP027856455 [A] 1-22 * the whole document *
by applicantJPS62249931
 EP0438750
 US5304633
    - FORD J.E. ET AL., JOURNAL OF PEDIATRICS, (1997), vol. 90, page 29
    - GALDIERO M, "Site-directed linker and insertion mutagenesis of herpes simplex virus type 1 glycoprotein", HJ VIROL, (1997), vol. 71, pages 2163 - 70
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.